鼻窦球囊扩张术治疗成人慢性鼻窦炎有效性和安全性的系统评价  

A systematic review of the efficacy and safety of sinus balloon dilatation in the treatment of chronic rhinosinusitis in adults

作　　者：刘文[1] 黄晓悫[1] LIU Wen;HUANG Xiaoque(Department of Otorhinolaryngology,Chong Gang General Hospital,Chongqing,400000,China)

机构地区：[1]重钢总医院耳鼻咽喉科,重庆400000

出　　处：《中国中西医结合耳鼻咽喉科杂志》2024年第3期190-196,共7页Chinese Journal of Otorhinolaryngology in Integrative Medicine

摘　　要：目的评价鼻窦球囊扩张术(SBCD)治疗成人慢性鼻窦炎的疗效及安全性。方法检索Pubmed、Medline、CNKI、CBM、维普、万方数据库,收集所有符合纳入标准的随机对照研究,采用Revman5.4软件对提取的数据进行Meta分析。结果共纳入13个研究。Meta分析显示:SBCD组与对照组成功扩张窦口比率相当;SBCD组术后3月SNOT-20评分、术后6月SNOT-20评分、术后3月Lund-Kennedy内镜评分、术后3月嗅觉功能正常比率与对照组比较,差异无统计学意义;SBCD组术后并发症发生率低于对照组,差异有统计学意义。结论鼻窦球囊扩张术治疗成人慢性鼻窦炎效果与功能性鼻内镜鼻窦手术相当,并发症发生率更低,在临床治疗中值得推广。Objective To evaluate the efficacy and safety of sinus balloon dilatation(SBCD)in the treatment of adult chronic rhinosinusitis.Methods PubMed,Medline,CNKI,CBM,VIP and Wanfang databases were searched,and all randomized controlled studies meeting the inclusion criteria were collected.Meta-analysis was performed on the extracted data using Revman5.4.Results A total of 13 studies were included.Meta-analysis showed that the ratio of successful sinus ostium dilation in SBCD group was similar to that in control group.There was no significant difference between SBCD group and control group in SNOT-20 score 3 months after surgery,SNOT-20 score 6 months after surgery,Lund Kennedy endoscopy score 3 months after surgery,and ratio of normal olfactory function 3 months after surgery.The incidence of postoperative complications in SBCD group was lower than that in control group,and the difference was statistically significant.Conclusion The effect of sinus balloon dilatation in the treatment of adult chronic rhinosinusitis is comparable to that of functional nasal endoscopic sinus surgery,and the complication rate is lower,so it is worth promoting in clinical treatment.

关 键 词：鼻窦球囊扩张术 鼻窦炎 META分析 

分 类 号：R765.9[医药卫生—耳鼻咽喉科]